AIRIS Mechanism-Informed Multimodal Generative AI for Causal and Dynamical Modelling in Biomedical Research
- Coordinator
- Athina-Erevnitiko Kentro Kainotomias Stis Technologies Tis Pliroforias, Ton Epikoinonion Kai Tis Gnosis, Greece
- Runs
- 1 June 2026 to 31 May 2030
- Status
- Running
- EU funding
- €16.9m
- Total cost
- €16.9m
- Partners
- 22 organisations in 11 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101289094
What the project is doing
In the project's own words, from its summary on CORDIS.
AIRIS will develop the next generation of multimodal Generative AI (GenAI) models to accelerate research on predictive and personalised medicine. Building on recent advances in LLMs, causal inference and mechanistic modelling, AIRIS will integrate heterogeneous biomedical data (omics, imaging, clinical, laboratory, lifestyle, PROMs and scientific literature) into mechanism-informed generative frameworks. These models will not only generate biologically plausible synthetic data to address sparsity and bias but also embed causal and dynamical constraints across biological scales, from “virtual cells” to multi-organ models, enabling counterfactual reasoning and in-silico hypothesis testing.
The project will deliver (i) robust agentic multimodal data integration pipelines; (ii) novel mechanism-anchored generative architectures with interpretability and bias-mitigation safeguards; (iii) hypothesis generation assistants for biomarker discovery, drug repurposing, and intervention design; and (iv) a scalable MLOps infrastructure ensuring reproducibility. AIRIS will be validated using already existing large-scale datasets in five high-impact use cases including Pulmonary Fibrosis, Steatotic Liver Disease, Cardiovascular Disease, Chronic Kidney Disease and Inflammatory Bowel Disease.
AIRIS will demonstrate utility in modelling of disease, while also allowing cross-disease insights. A multidisciplinary consortium spanning leading universities and research centres, HPC experts, industry, and SME ensures excellence across the project dimensions. ELSI and fairness will be systematically addressed by SSH and legal experts. Outputs will be openly disseminated through benchmarks, training, and open-source releases, fostering European leadership in mechanism-informed GenAI.
AIRIS will maximise scientific, clinical, and societal impact by bridging AI innovation with biomedical discovery, improving disease understanding, and supporting equitable personalised care.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Athina-Erevnitiko Kentro Kainotomias Stis Technologies Tis Pliroforias, Ton Epikoinonion Kai Tis Gnosis | Maroussi | Greece | Coordinator |
| Katholieke Universiteit Leuven | Leuven | Belgium | Participant |
| Timelex | Bruxelles / Brussel | Belgium | Participant |
| The Research Institute of the Mcgill University Health Centre | Montreal | Canada | Participant |
| Centre Hospitalier Universitaire Vaudois | Lausanne | Switzerland | Participant |
| Universitaet Bern | Bern | Switzerland | Participant |
| Eurice European Research and Project Office GmbH | St Ingbert | Germany | Participant |
| Forschungszentrum Julich GmbH | Julich | Germany | Participant |
| Technische Universitaet Muenchen | Muenchen | Germany | Participant |
| Universitaetsklinikum Aachen | Aachen | Germany | Participant |
| A. Persidis & Sia Oe | Athina | Greece | Participant |
| Charokopeio Panepistimio | Athina | Greece | Participant |
| Institut Catala De La Salut | Barcelona | Spain | Participant |
| Alma Mater Studiorum - Universita Di Bologna | Bologna | Italy | Participant |
| Azienda Usl Della Romagna | Ravenna | Italy | Third party |
| Elsevier BV | Amsterdam | Netherlands | Participant |
| Universiteit Van Amsterdam | Amsterdam | Netherlands | Participant |
| Linkopings Universitet | Linkoping | Sweden | Participant |
| The University of Manchester | Manchester | United Kingdom | Participant |
| University College London | London | United Kingdom | Participant |
| Mlcommons Association | Dover | United States | Participant |
| Yale University | New Haven | United States | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI